NOW APPROVED
In Advanced NSCLC

LIBTAYO is a prescription medicine used to treat people with a type of lung cancer called non–small cell lung cancer (NSCLC) that has not spread outside your chest (locally advanced lung cancer) and you cannot have surgery or chemotherapy with radiation, or your lung cancer has spread to other areas of your body (metastatic lung cancer), and your tumor tests positive for high "PD-L1," and your tumor does not have an abnormal "EGFR," "ALK," or "ROS1" gene.

Patient portrayal

Patient portrayal.

LIBTAYO may be used as your first treatment in advanced NSCLC

View full Prescribing Information, including Medication Guide

LIBTAYO is not chemotherapy or radiation therapy—it is an immunotherapy that works with your immune system

Download the LIBTAYO fact sheet
LIBTAYO Surround® logo

LIBTAYO Surround may be able to provide you with resources and support to assist you.

Learn about the LIBTAYO Surround Patient Support Program